The global autoimmune disease diagnostics market is expected to reach USD 20.4 billion by 2021 from USD 14.3 billion in 2016. During this period, the CAGR is expected to be 6.04%
Autoimmune diseases are a group of diseases characterized by inflammatory reactions caused by immune responses mistakenly generated against body tissues. Rheumatoid arthritis is an example of an autoimmune disease that affects women more than men. Recent discoveries in diagnostic techniques in autoimmune disease are driving the market. Although the disease is rare, continuous innovations and developments in the diagnostic provide market opportunities for industry participants.
Global Autoimmune Disease Diagnostics Market- Market Dynamics
The report details several driving and restraining factors for the autoimmune disease diagnostics market. Some of these are listed below.
Slow turnaround time for autoimmune disease diagnostic test results and high frequency of false positive results are the factors which are slowing down the market.
Despite the lower incidence and prevalence rate, the market size of Southern Asia is sizable because of its large population. Western countries show increasing incidence of autoimmune disorder because of the changing lifestyle, hygiene, and unhealthy eating. Revenue growth is primarily driven in the United States market where the incidence of gastrointestinal autoimmune conditions primarily celiac disease is on the rise. In the US alone, 8% of the population suffers from autoimmune diseases, 78% of which are women.
Global autoimmune disease diagnostics market is segmented based on type (localized autoimmune disease diagnostic and systemic autoimmune disease diagnostic ), products( drugs, therapeutic and monitoring equipment, diagnostic equipment), service market( consultation and diagnosis, therapy & monitoring, drug development and discovery), technology( bridge therapy, DMARD, topical therapy, phototherapy, helminthic therapy, recombinant technology)and geography( US, Europe, Asia-Pacific, RoW).
Some of the key players in the market are:
What the Report Offers
Reasons for Buying this Report